Document ID: chunk:federal_register_of_legislation:F2018C00617:reg:9:p2
Version: federal_register_of_legislation:F2018C00617
Segment Type: reg
Provision Reference: reg 9 (pt 2/2)
Character Range: 5085–6556

screening tests:
              (a) the information that must be notified to the Commonwealth Chief Medical Officer; and
              (b) the individual healthcare provider who must notify the information; and
              (c) the time by which the information must be notified.

       7  Purposes of this Part

         This Part is made for the purposes of subsection 13(1) of the Act.

       8  Colposcopies

        (1) This section applies to a type of screening test to which all of the following paragraphs apply:
           (a) the screening test is associated with cervical cancer;
           (b) the screening test is a colposcopy;
           (c) the screening test is carried out by an individual healthcare provider;
           (d) the screening test is carried out other than as part of a clinical trial approved by an ethics committee (within the meaning of the Therapeutic Goods Act 1989).

            Note: Section 4 of the Act defines screening test to mean a test or procedure as part of screening.

        (2) If a screening test of that type is carried out, the individual healthcare provider who carries out the screening test must, under subsection 13(1) of the Act, notify the Commonwealth Chief Medical Officer, by the end of 14 days after the day the colposcopy is completed, of the information specified in the following table.

Information for colposcopies
Item                          Column 1
                              Information